论文部分内容阅读
AIM:To investigate whether selenomethionine(SLM)reduces mucositis incidence in patients with head and neck squamous cell cancer(HNSCC)undergoing concurrent chemoradiation(CRT).METHODS:In this multi-institutional,randomized,double-blind phaseⅡtrial,patient